{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:26:27Z","timestamp":1791599187344,"version":"4.3.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Syst. Neurosci."],"abstract":"<jats:p>Pathological proteins contributing to Alzheimer\u2019s disease (AD) are known to disrupt normal neuronal functions in the brain, leading to unbalanced neuronal excitatory-inhibitory tone, distorted neuronal synchrony, and network oscillations. However, it has been proposed that abnormalities in neuronal activity directly contribute to the pathogenesis of the disease, and in fact it has been demonstrated that induction of synchronized 40 Hz gamma oscillation of neuronal networks by sensory stimulation reverses AD-related pathological markers in transgenic mice carrying AD-related human pathological genes. Based on these findings, the current study evaluated whether non-invasive sensory stimulation inducing cortical 40 Hz gamma oscillation is clinically beneficial for AD patients. Patients with mild to moderate AD (<jats:italic>n<\/jats:italic> = 22) were randomized to active treatment group (<jats:italic>n<\/jats:italic> = 14; gamma sensory stimulation therapy) or to sham group (<jats:italic>n<\/jats:italic> = 8). Participants in the active treatment group received precisely timed, 40 Hz visual and auditory stimulations during eye-closed condition to induce cortical 40 Hz steady-state oscillations in 1-h daily sessions over a 6-month period. Participants in the sham group were exposed to similar sensory stimulation designed to not evoke cortical 40 Hz steady-state oscillations that are observed in the active treatment patients. During the trial, nighttime activities of the patients were monitored with continuous actigraphy recordings, and their functional abilities were measured by Alzheimer\u2019s Disease Cooperative Study \u2013 Activities of Daily Living (ADCS-ADL) scale. Results of this study demonstrated that 1-h daily therapy was well tolerated throughout the 6-month treatment period by all subjects. Patients receiving gamma sensory stimulation showed significantly reduced nighttime active periods, in contrast, to deterioration in sleep quality in sham group patients. Patients in the sham group also showed the expected, significant decline in ADCS-ADL scores, whereas patients in the gamma sensory stimulation group fully maintained their functional abilities over the 6-month period. These findings confirm the safe application of 40 Hz sensory stimulation in AD patients and demonstrate a high adherence to daily treatment. Furthermore, this is the first time that beneficial clinical effects of the therapy are reported, justifying expanded and longer trials to explore additional clinical benefits and disease-modifying properties of gamma sensory stimulation therapy.<\/jats:p><jats:p><jats:bold>Clinical Trial Registration:<\/jats:bold><jats:ext-link>clinicaltrials.gov<\/jats:ext-link>, identifier: NCT03556280.<\/jats:p>","DOI":"10.3389\/fnsys.2021.746859","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:56:31Z","timestamp":1632531391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":113,"title":["Sensory-Evoked 40-Hz Gamma Oscillation Improves Sleep and Daily Living Activities in Alzheimer\u2019s Disease Patients"],"prefix":"10.3389","volume":"15","author":[{"given":"Aylin","family":"Cimenser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Travers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Strozewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Malchano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Haj\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e928","DOI":"10.1016\/j.neuron.2019.04.011","article-title":"Gamma entrainment binds higher-order brain regions and offers neuroprotection.","volume":"92","author":"Adaikkan","year":"2019","journal-title":"Neuron"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1111\/j.1532-5415.2008.01934.x","article-title":"Cognitive effects of treating obstructive sleep apnea in Alzheimer\u2019s disease: a randomized controlled study.","volume":"56","author":"Ancoli-Israel","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"B3","doi-asserted-by":"publisher","first-page":"101250","DOI":"10.1016\/j.smrv.2019.101250","article-title":"Obstructive sleep apnea, cognition and Alzheimer\u2019s disease: a systematic review integrating three decades of multidisciplinary research.","volume":"50","author":"Bubu","year":"2020","journal-title":"Sleep Med. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/psyg.12474","article-title":"Actigraphic, but not subjective, sleep measures are associated with cognitive impairment in memory clinic patients.","volume":"20","author":"Cabanel","year":"2020","journal-title":"Psychogeriatrics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2174\/1567205016666191010124011","article-title":"Actigraphy for assessing light effects on sleep and circadian activity rhythm in Alzheimer\u2019s dementia: a narrative review.","volume":"16","author":"Canazei","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature20412","article-title":"The road to restoring neural circuits for the treatment of Alzheimer\u2019s disease.","volume":"539","author":"Canter","year":"2016","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.nbd.2018.05.020","article-title":"Neuronal levels and sequence of tau modulate the power of brain rhythms.","volume":"117","author":"Das","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11920-009-0004-2","article-title":"Current treatments for sleep disturbances in individuals with dementia.","volume":"11","author":"Deschenes","year":"2009","journal-title":"Curr. Psychiatry Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease.","volume":"369","author":"Doody","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease.","volume":"370","author":"Doody","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s disease. the Alzheimer\u2019s disease cooperative study.","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e12178","DOI":"10.1002\/trc2.12178","article-title":"A feasibility trial of gamma sensory flicker for patients with prodromal Alzheimer\u2019s disease.","volume":"7","author":"He","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"B13","first-page":"53","article-title":"Sleep and attention in Alzheimer\u2019s disease.","volume":"92","author":"Hennawy","year":"2019","journal-title":"Yale J. Biol. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/alz.12035","article-title":"Polysomnographic assessment of suvorexant in patients with probable Alzheimer\u2019s disease dementia and insomnia: a randomized trial.","volume":"16","author":"Herring","year":"2020","journal-title":"Alzheimers Dement"},{"key":"B15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s002210100682","article-title":"Human EEG responses to 1-100 Hz flicker: resonance phenomena in visual cortex and their potential correlation to cognitive phenomena.","volume":"137","author":"Herrmann","year":"2001","journal-title":"Exp. Brain Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"101271","DOI":"10.1016\/j.isci.2020.101271","article-title":"Hyperexcitable parvalbumin interneurons render hippocampal circuitry vulnerable to amyloid beta.","volume":"23","author":"Hijazi","year":"2020","journal-title":"iScience"},{"key":"B17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature20587","article-title":"Gamma frequency entrainment attenuates amyloid load and modifies microglia.","volume":"540","author":"Iaccarino","year":"2016","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1172\/JCI130513","article-title":"Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.","volume":"130","author":"Kang","year":"2020","journal-title":"J. Clin. Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"10008","DOI":"10.1209\/0295-5075\/102\/10008","article-title":"Asymmetry and basic pathways in sleep-stage transitions.","volume":"102","author":"Lo","year":"2013","journal-title":"Europhys. Lett."},{"key":"B20","doi-asserted-by":"crossref","first-page":"17545","DOI":"10.1073\/pnas.0408242101","article-title":"Common scale-invariant patterns of sleep\u2013wake transitions across mammalian species.","volume":"101","author":"Lo","year":"2004","journal-title":"PNAS"},{"key":"B21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1209\/epl\/i2002-00508-7","article-title":"Dynamics of sleep-wake transitions during sleep.","volume":"57","author":"Lo","year":"2002","journal-title":"Europhys. Lett."},{"key":"B22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3233\/JAD-161287","article-title":"Is sleep disruption a risk factor for Alzheimer\u2019s disease?","volume":"58","author":"Macedo","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nn.4035","article-title":"beta-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation.","volume":"18","author":"Mander","year":"2015","journal-title":"Nat. Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cell.2019.02.014","article-title":"Multi-sensory gamma stimulation ameliorates Alzheimer\u2019s-Associated pathology and improves cognition.","volume":"177","author":"Martorell","year":"2019","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease.","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B26","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/JGP.0b013e318252e3ff","article-title":"Discrepancy between subjective and objective sleep disturbances in early- and moderate-stage Alzheimer disease.","volume":"20","author":"Most","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","article-title":"Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction.","volume":"2","author":"Mucke","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11940-016-0424-423","article-title":"Treatment of sleep disorders in dementia.","volume":"18","author":"Ooms","year":"2016","journal-title":"Curr. Treat Options Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.smrv.2014.03.007","article-title":"Sleep and Alzheimer\u2019s disease.","volume":"19","author":"Peter-Derex","year":"2015","journal-title":"Sleep Med. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.5664\/jcsm.7228","article-title":"Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: an american academy of sleep medicine systematic review, meta-analysis, and GRADE assessment.","volume":"14","author":"Smith","year":"2018","journal-title":"J. Clin. Sleep Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1513\/AnnalsATS.201610-816OC","article-title":"Changes in habitual sleep duration after continuous positive airway pressure for obstructive sleep apnea.","volume":"14","author":"Tachikawa","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41181-019-0070-77","article-title":"Current radiotracers to image neurodegenerative diseases.","volume":"4","author":"Tiepolt","year":"2019","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.smrv.2017.07.005","article-title":"Sleep and Alzheimer\u2019s disease: a pivotal role for the suprachiasmatic nucleus.","volume":"40","author":"Van Erum","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2165\/00023210-200115100-200115104","article-title":"Sleep disturbances in patients with Alzheimer\u2019s disease: epidemiology, pathophysiology and treatment.","volume":"15","author":"Vitiello","year":"2001","journal-title":"CNS Drugs"},{"key":"B35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-019-0478-475","article-title":"Bidirectional relationship between sleep and Alzheimer\u2019s disease: role of amyloid, tau, and other factors.","volume":"45","author":"Wang","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fphys.2020.00294","article-title":"Non-invasive 40-Hz light flicker ameliorates Alzheimer\u2019s-Associated rhythm disorder via regulating central circadian clock in mice.","volume":"11","author":"Yao","year":"2020","journal-title":"Front. Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.bbrc.2020.03.004","article-title":"Driving GABAergic neurons optogenetically improves learning, reduces amyloid load and enhances autophagy in a mouse model of Alzheimer\u2019s disease.","volume":"525","author":"Zhang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e18405","DOI":"10.1097\/MD.0000000000018405","article-title":"High prevalence of sleep disorders and behavioral and psychological symptoms of dementia in late-onset Alzheimer disease: a study in Eastern China.","volume":"98","author":"Zhou","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Frontiers in Systems Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnsys.2021.746859\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:56:35Z","timestamp":1632531395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnsys.2021.746859\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":38,"alternative-id":["10.3389\/fnsys.2021.746859"],"URL":"https:\/\/doi.org\/10.3389\/fnsys.2021.746859","relation":{},"ISSN":["1662-5137"],"issn-type":[{"value":"1662-5137","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"article-number":"746859"}}